Cargando…

Immunization of children with inflammatory bowel disease against SARS-CoV-19 infection: A prospective single centre cohort study

BACKGROUND: Real-world data of children with inflammatory bowel disease (IBD) after SARS-CoV-2 vaccination are needed. METHOD: This prospective, observational study evaluate antibody kinetics of children with IBD 6 months after immunization with COVID-19 mRNA vaccine. RESULTS: 24 children with IBD w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dohos, Dóra, Karoliny, Anna, Gombos, Eszter, Rimanóczy, Éva, Müller, Katalin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Short communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562902/ https://www.ncbi.nlm.nih.gov/pubmed/37822890 http://dx.doi.org/10.1016/j.jvacx.2023.100374

Ejemplares similares

Hungarian Linguistic, Cross-Cultural and Age Adaptation of Transition Specific Questionnaires in Patients with Inflammatory Bowel Disease
por: Dohos, Dóra, et al.
Publicado: (2023)

Body composition, physical activity, and quality of life in pediatric patients with inflammatory bowel disease on anti-TNF therapy—an observational follow-up study
por: Boros, Kriszta Katinka, et al.
Publicado: (2022)

Hungarian Linguistic, Cross-Cultural, and Age Adaptation of the Patient Satisfaction with Health Care in Inflammatory Bowel Disease Questionnaire (CACHE) and the Medication Adherence Report Scale (MARS)
por: Dohos, Dóra, et al.
Publicado: (2022)

Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease
por: Calafat, Margalida, et al.
Publicado: (2021)

Incidence and Paris Classification of Pediatric Inflammatory Bowel Disease
por: Eszter Müller, Katalin, et al.
Publicado: (2014)

Effect of joint transition visits on quality of life in adolescents with inflammatory bowel diseases: a protocol for a prospective, randomised, multicentre, controlled trial (TRANS-IBD)
por: Erős, Adrienn, et al.
Publicado: (2020)

Corrigendum to “Incidence and Paris Classification of Pediatric Inflammatory Bowel Disease”
por: Müller, Katalin Eszter, et al.
Publicado: (2015)

Systematic review with meta‐analysis: the effects of immunomodulator or biological withdrawal from mono‐ or combination therapy in inflammatory bowel disease
por: Dohos, Dóra, et al.
Publicado: (2020)

Adherence to the Porto Criteria Based on the Hungarian Nationwide Pediatric Inflammatory Bowel Disease Registry (HUPIR)
por: Müller, Katalin E., et al.
Publicado: (2021)

Serological response to vaccination against coronavirus disease-19 in patients with inflammatory bowel disease
por: Mathur, Akash, et al.
Publicado: (2023)

SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
por: Quan, Joshua, et al.
Publicado: (2022)

Prospects for controlling future pandemics of SARS in highlights of SARS-CoV-2
por: Basnet, Buddha Bahadur, et al.
Publicado: (2021)

Specific nasopharyngeal Corynebacterium strains serve as gatekeepers against SARS-CoV-2 infection
por: Szabo, Dora, et al.
Publicado: (2023)

SARS-CoV-2 seropositivity and subsequent infection risk: a prospective cohort study
por: Syed, Dr. Mohamed Ahmed, et al.
Publicado: (2022)

Serological response to vaccines against SARS-CoV-2 in patients with inflammatory bowel disease
por: Algaba, Alicia, et al.
Publicado: (2023)

Anal carcinoma in inflammatory bowel disease
por: Frisch, M, et al.
Publicado: (2000)

Recent advances in inflammatory bowel disease
por: Al Dulaimi, David
Publicado: (2015)

Recent advances in inflammatory bowel disease
por: Polewiczowska, Beata, et al.
Publicado: (2017)

Phytochemicals against SARS-CoV as potential drug leads
por: Swain, Shasank Sekhar, et al.
Publicado: (2021)

Hospital-wide SARS-CoV-2 antibody screening of staff in a university psychiatric centre in Belgium
por: El Abdellati, Kawtar, et al.
Publicado: (2021)

The Impact of SARS-CoV-2 on Inflammatory Bowel Disease
por: Estevinho, Maria Manuela, et al.
Publicado: (2020)

Su1484: SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
por: Quan, Joshua, et al.
Publicado: (2022)

mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021
por: McLean, Huong Q., et al.
Publicado: (2022)

Collaborated effort against SARS‐CoV‐2 outbreak in China
por: Yang, Qiwen, et al.
Publicado: (2020)

In vitro efficacy of Artemisia extracts against SARS-CoV-2
por: Nie, Chuanxiong, et al.
Publicado: (2021)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

An observational study of a cohort of citizens receiving the AZD1222 vaccine against SARS-CoV-2
por: Cerino, Pellegrino, et al.
Publicado: (2021)

Influenza vaccination coverage in children with inflammatory bowel disease
por: Banaszkiewicz, Aleksandra, et al.
Publicado: (2014)

Systematic SARS-CoV-2-testing for asymptomatic cancer patients treated at a public healthcare tertiary centre in Brazil
por: Fares, Aline F, et al.
Publicado: (2021)

An in vitro antiviral activity of iodine complexes against SARS-CoV-2
por: Altaf, Imran, et al.
Publicado: (2021)

Breastfeeding importance and its therapeutic potential against SARS‐CoV‐2
por: Vasques da Costa, Aline, et al.
Publicado: (2021)

Antiviral activity of salt-coated materials against SARS-CoV-2
por: Coleman, Christopher M., et al.
Publicado: (2023)

Vaccination against SARS-CoV-2 in a rural Ugandan population
por: Mugisha, Joseph, et al.
Publicado: (2023)

Fibre intake and the development of inflammatory bowel disease: A European prospective multi-centre cohort study (EPIC-IBD)
por: Andersen, Vibeke, et al.
Publicado: (2018)

Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
por: Tepasse, Phil-Robin, et al.
Publicado: (2021)

Therapeutic Decisions in Inflammatory Bowel Disease in the SARS-Cov-2 Pandemic
por: Brain, Oliver, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease
por: Garrido, Hannah M Garcia, et al.
Publicado: (2021)

Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection
por: Dvornikova, K. A., et al.
Publicado: (2021)

Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses
por: Joseph, Jeswin, et al.
Publicado: (2021)

The fungal microbiota of de-novo paediatric inflammatory bowel disease
por: Mukhopadhya, I., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0jc5hctf5b4nlrv95u7tael7qp